Walmart Partners With Novo Nordisk To Launch US Private-Label Insulin

Company Launches Insulin Aspart And FlexPens As Interchangeable Biosimilars Loom

Walmart
Walmart says it aims to increase access and affordability through its private brand analog insulin launch • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin